Eli Lilly will buy autoimmune drug developer Ventyx Biosciences for $1.2 billion in cash, the companies said on Wednesday, ...
Eli Lilly shares are trading higher Wednesday following a report suggesting the company is nearing a deal for Ventyx Biosciences.
Companies in the Energy sector have received a lot of coverage today as analysts weigh in on Chevron (CVX – Research Report), Schlumberger (SLB – Research Report) and China Sh ...
However, a pie-in-the-sky addressable market doesn't mean every AI stock will be a winner. In 2026, two unstoppable AI stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results